Lithuanian Biotech Database

Biotechgate

Biotechgate Global Database › Global Trial › Global Log-in ›

Database Life Science Map Statistics News & Events About us

News in the Life Sciences Industry
Results 1 - 20 out of 49 displayed.
1 2 3 »

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 26 Sep 2022

More people with type 2 diabetes achieved blood sugar target with once-weekly insulin icodec compared with once-daily insulin degludec

Read more ››

By: GlobenewsWire - 22 Sep 2022

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 19 Sep 2022

Novo Nordisk and Microsoft collaborate to accelerate drug discovery and development using big data and artificial intelligence

Read more ››

By: GlobenewsWire - 12 Sep 2022

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 12 Sep 2022

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 05 Sep 2022

Novo Nordisk to acquire Forma Therapeutics and expand presence in sickle cell disease and rare blood disorders

Read more ››

By: GlobenewsWire - 01 Sep 2022

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 29 Aug 2022

Novo Nordisk successfully completes phase 2 trial with CagriSema in people with type 2 diabetes

Read more ››

By: GlobenewsWire - 22 Aug 2022

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 22 Aug 2022

Novo Nordisk A/S: Share repurchase programme

Read more ››

By: GlobenewsWire - 15 Aug 2022

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

Read more ››

By: GlobenewsWire - 08 Aug 2022

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons

Read more ››

By: GlobenewsWire - 05 Aug 2022

Novo Nordisk's sales increased by 25% in Danish kroner and by 16% at constant exchange rates to DKK 83.3 billion in the first six months of 2022

Read more ››

By: GlobenewsWire - 03 Aug 2022

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 03 Aug 2022

Novo Nordisk achieves primary objectives of ONWARDS 3 and 4 trials with once-weekly insulin icodec demonstrating superior reduction in HbA1c vs insulin degludec in ONWARDS 3

Read more ››

By: GlobenewsWire - 29 Jul 2022

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 25 Jul 2022

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 18 Jul 2022

Novo Nordisk A/S – Share repurchase programme

Read more ››

By: GlobenewsWire - 11 Jul 2022

Novo Nordisk A/S: Mim8 phase 1 & 2 data demonstrates potential as once monthly treatment for people with haemophilia A

Read more ››

By: GlobenewsWire - 11 Jul 2022

Looking for companies outside of Lithuania?

Browse our global Life Sciences lead sourcing platform Biotechgate for company information, product pipelines, licensing opportunities, management details and much more.

Partners

Upcoming Life Sciences Events

September 2022
- BioPharm America™ 2022
October 2022
- Lisbon: Neuro, Digital & A.I. Innovation Summit
- BIO-Europe® 2022

Add an Event »

Latest company news

Novo Nordisk A/S – Share repurchase programme
26 Sep 2022 (GlobenewsWire)

More people with type 2 diabetes achieved blood sugar target with once-weekly insulin icodec compared with once-daily insulin degludec
22 Sep 2022 (GlobenewsWire)

Novo Nordisk A/S – Share repurchase programme
19 Sep 2022 (GlobenewsWire)

Biotechgate database

About Biotechgate
The Lithuanian Biotech Database is a product of Venture Valuation and part of the global Life Sciences lead generation and intelligence platform Biotechgate. Our mission is to provide up-to-date company and business information of the Biotech, Pharma and Medtech sectors to professionals everywhere, in order to support them in identifying the most appropriate business partners, customers and suppliers.

Visit our global portal: www.biotechgate.com